Mendelian inheritance of familial prostate cancer
- PMID: 1565627
- PMCID: PMC48868
- DOI: 10.1073/pnas.89.8.3367
Mendelian inheritance of familial prostate cancer
Abstract
Previous studies have demonstrated familial clustering of prostate cancer. To define the nature of this familial aggregation and to assess whether Mendelian inheritance can explain prostate cancer clustering, proportional hazards and segregation analyses were performed on 691 families ascertained through a single prostate cancer proband. The proportional hazards analyses revealed that two factors, early age at onset of disease in the proband and multiple affected family members, were important determinants of risk of prostate cancer in these families. Furthermore, segregation analyses revealed that this clustering can be best explained by autosomal dominant inheritance of a rare (q = 0.0030) high-risk allele leading to an early onset of prostate cancer. The estimated cumulative risk of prostate cancer for carriers revealed that the allele was highly penetrant: by age 85, 88% of carriers compared to only 5% of noncarriers are projected to be affected with prostate cancer. The best fitting autosomal dominant model further suggested that this inherited form of prostate cancer accounts for a significant proportion of early onset disease but overall is responsible for a small proportion of prostate cancer occurrence (9% by age 85). These data provide evidence that prostate cancer is inherited in Mendelian fashion in a subset of families and provide a foundation for gene mapping studies of heritable prostate cancer. Characterization of genes involved in inherited prostate cancer could provide important insight into the development of this disease in general.
Similar articles
-
Autosomal dominant inheritance of prostate cancer: a confirmatory study.Urology. 2001 Jan;57(1):97-101. doi: 10.1016/s0090-4295(00)00891-8. Urology. 2001. PMID: 11164151
-
Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.Ann Hum Genet. 2003 Mar;67(Pt 2):125-37. doi: 10.1046/j.1469-1809.2003.00022.x. Ann Hum Genet. 2003. PMID: 12675688
-
Segregation analysis of prostate cancer in Sweden: support for dominant inheritance.Am J Epidemiol. 1997 Oct 1;146(7):552-7. doi: 10.1093/oxfordjournals.aje.a009313. Am J Epidemiol. 1997. PMID: 9326432
-
Familial risk factors for prostate cancer.Cancer Surv. 1991;11:5-13. Cancer Surv. 1991. PMID: 1841757 Review.
-
[Heredity in renal and prostatic neoplasia].Arch Ital Urol Androl. 1997 Sep;69(4):241-6. Arch Ital Urol Androl. 1997. PMID: 9417296 Review. Italian.
Cited by
-
[Prostate and breast cancer: similarities and differences].Urologie. 2022 Oct;61(10):1068-1075. doi: 10.1007/s00120-022-01913-5. Epub 2022 Aug 29. Urologie. 2022. PMID: 36038785 Review. German.
-
Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations.J Genet Couns. 2014 Apr;23(2):187-91. doi: 10.1007/s10897-013-9629-8. Epub 2013 Jul 25. J Genet Couns. 2014. PMID: 23881471
-
The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel.Fam Cancer. 2006;5(4):389-95. doi: 10.1007/s10689-006-0010-z. Epub 2006 Aug 31. Fam Cancer. 2006. PMID: 16944274
-
Prostate cancer: 3. Individual risk factors.CMAJ. 1998 Oct 6;159(7):807-13. CMAJ. 1998. PMID: 9805030 Free PMC article. Review. No abstract available.
-
Bladder cancer following prostate cancer--an analysis of risk factors.Int Urol Nephrol. 1994;26(1):43-51. doi: 10.1007/BF02768243. Int Urol Nephrol. 1994. PMID: 8026922
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical